Lasa Supergenerics Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This disclosure is a routine regulatory requirement.
Lasa Supergenerics submitted its Annual Secretarial Compliance Report for the year ended March 31, 2026. The report details governance compliance and historical penalties paid for procedural delays.
Lasa Supergenerics Limited disclosed Related Party Transactions totaling 35.36 for the period ending March 2026. The report ensures regulatory compliance and transparency regarding promoter-related dealings.